Aspire Biopharma Holdings, Inc. Interest Expense, Debt
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2025-08-13
- Aspire Biopharma Holdings, Inc. interest expense, debt for the quarter ending 2025-06-30 was $527.89K.
- Aspire Biopharma Holdings, Inc. interest expense, debt for the quarter ending 2025-03-31 was $289.93K, a 58.16% increase year-over-year.
- Aspire Biopharma Holdings, Inc. interest expense, debt for the quarter ending 2024-03-31 was $183.31K.
- Aspire Biopharma Holdings, Inc. interest expense, debt for fiscal 2024 was $891.62K, a 9844.50% increase from fiscal 2023.
- Aspire Biopharma Holdings, Inc. interest expense, debt for fiscal 2023 was $8.97K.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 12 month |
|---|---|---|---|
| 2025-06-30 | $527.89K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-13 | $817.82K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $289.93K 10-Q/A · filed 2025-08-13 | ||
| 2024-12-31 | $891.62K 10-K · filed 2025-04-07 | ||
| 2024-03-31 | $183.31K 10-Q · filed 2024-06-05 | ||
| 2023-12-31 | $8.97K 10-K · filed 2025-04-07 |